Literature DB >> 9204962

Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds.

M Vaalamo1, L Mattila, N Johansson, A L Kariniemi, M L Karjalainen-Lindsberg, V M Kähäri, U Saarialho-Kere.   

Abstract

Proteolysis is an intrinsic component of cutaneous wound repair and several matrix metalloproteinases have been shown to participate in various stages of this process. Therefore, we investigated the expression of a novel metalloproteinase, collagenase-3 (MMP-13), in normally healing cutaneous wounds and chronic venous ulcers. MMP-13 was expressed abundantly by fibroblasts deep in the chronic ulcer bed but was not detected in epidermis and all the acute wounds. The spatial expression of MMP-13 differed from that of collagenase-1 (MMP-1), which was prominently expressed by migrating keratinocytes and dermal cells located just beneath the wound surface. Northern blot hybridization did not reveal expression of MMP-13 by fibroblasts cultured on tissue culture plastic. In accordance with our in vivo findings, however, fibroblasts grown in a collagen gel produced MMP-13 mRNA abundantly. Our results suggest that MMP-13 can be induced in skin during wound repair after altered cell-matrix interactions. Although both MMP-1 and MMP-13 have the unique ability to degrade fibrillar collagens, their regulation and role during wound repair seem different. Collagenase-1 is critical for re-epithelialization, and MMP-13 most likely plays a role in the remodeling of collagenous matrix in chronic wounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204962     DOI: 10.1111/1523-1747.ep12276722

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  48 in total

Review 1.  Integrin signaling in fibrosis and scleroderma.

Authors:  H A Gardner
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

2.  Activation of neutrophil collagenase in periodontitis.

Authors:  R Romanelli; S Mancini; C Laschinger; C M Overall; J Sodek; C A McCulloch
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

4.  Basal and steroid hormone-regulated expression of CXCR4 in human endometrium and endometriosis.

Authors:  Abigail Ruiz; Virgilio A Salvo; Lynnette A Ruiz; Perla Báez; Miosotis García; Idhaliz Flores
Journal:  Reprod Sci       Date:  2010-08-18       Impact factor: 3.060

Review 5.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

6.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.

Authors:  N Johansson; K Airola; R Grénman; A L Kariniemi; U Saarialho-Kere; V M Kähäri
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

7.  Efficacy of glutathione mesotherapy in burns: an experimental study.

Authors:  A Buz; T Görgülü; A Olgun; E Kargi
Journal:  Eur J Trauma Emerg Surg       Date:  2015-11-27       Impact factor: 3.693

Review 8.  Collagenase and surgical disease.

Authors:  Timothy R Donahue; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

9.  Activation of the Wnt/β-catenin pathway and tissue inhibitor of metalloprotease 1 during tertiary dentinogenesis.

Authors:  Seisuke Yoshioka; Yusuke Takahashi; Makoto Abe; Ikumi Michikami; Satoshi Imazato; Satoshi Wakisaka; Mikako Hayashi; Shigeyuki Ebisu
Journal:  J Biochem       Date:  2012-10-04       Impact factor: 3.387

10.  Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.

Authors:  M T Salmela; T T MacDonald; D Black; B Irvine; T Zhuma; U Saarialho-Kere; S L F Pender
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.